Inside this Issue: SBI 2022 Meeting Highlights, Legislative and Advocacy Update, ARRS 2022 Meeting highlights, and more! Continue Reading
News
Inside this Issue: An interview with #SBIACR2022 Keynote Dr. Hortobagyi, tips on starting a breast imaging research career, and much more! Continue Reading
Inside this Issue: MARCA and Averting Further Medicare Provider Payment Cuts, Difficult Conversations With Technologists and Administrators for Early-Career Radiologists, and much more! Continue Reading
Inside this Issue: #SBIACR2021 highlights, Virtual ACR 2021 recap, and more! Continue Reading
Inside this Issue: Lawrence W. Bassett, MD, FACR In Memoria, RSNA 2020 Annual Meetnig review, the All-New Young Physicians Section, and more! Continue Reading
Author: Janice S. Sung, MD, FSBIa Background: Limitations of screening mammography Mammography is the primary imaging modality used for breast cancer screening, as it is cost effective, widely available, and the only imaging modality validated by multiple randomized controlled trials and... Continue Reading
Author: Amy M. Fowler, MD, PhD Molecular imaging is a promising approach for achieving precision medicine. It can provide important functional information for improved diagnosis, treatment planning, prognostic and predictive information and evaluation of treatment response for cancer patients. The... Continue Reading
Author: Wendie A. Berg, MD, PhD, FACR, FSBI Adapted with permission from: Journal of Nuclear Medicine (Berg WA. Nuclear breast imaging: clinical results and future directions. Journal of Nuclear Medicine. 2016 Feb 1;57(Supplement 1):46S-52S.) Summarized by: Heidi Umphrey, MD, MS, FCAP Department... Continue Reading
Author: Maxine Jochelson, MD, FSBI The purpose of this paper is to address the importance of physiologic imaging for the staging and follow up of patients with breast cancer according to the principles of precision medicine. Precision medicine is the “tailoring of medical treatment to the... Continue Reading
Authors: John Lewin, MD, FSBI; Maxine Jochelson, MD, FSBI Introduction Screening mammography has been shown to reduce breast cancer mortality in randomized clinical trials. It has been an effective screening test for the past 4 decades due to its short exam time, patient convenience and low cost.... Continue Reading
Authors: Emily F. Conant, MD, FSBI; Liane Philpotts, MD, FSBI Digital breast tomosynthesis (DBT), which was FDA approved in 2011, is rapidly emerging as the new standard of care for x-ray imaging of the breast. Multiple studies have shown that when DBT is coupled with conventional 2D mammography,... Continue Reading